Search / 1987 results found

from
to
  • Updated

RADNOR, Pa., Dec. 3, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against D-MARKET Elektronik Hizmetler ve Ticaret Anonim Şirketi a/k/a D-MARKET Electronic Services & Trading d/b/a Hepsiburada ("Hepsiburada") (NASDAQ: HEPS). The action charges the company with violations of the federal securities laws, including omissions and fraudulent misrepresentations involving its American Depositary Receipts ("ADRs") pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with Hepsiburada's July 2021 initial public offering ("IPO"). Hepsiburada's materially misleading statements regarding their business, operations, and prospects caused investors to suffer significant losses.  

  • Updated

DENVER, Pa., Dec. 3, 2021 /PRNewswire/ -- Morphy's 45,000-square-foot gallery never looks more beautiful than just before the company's December Fine & Decorative Arts Auction. That's the time of year when visitors are greeted by a breathtaking array of Tiffany Studios lamps, fine jewelry, paintings, both European and American pottery and glass, and many other superior-quality art objects carefully curated by Morphy's specialists.

  • Updated

CENTER VALLEY, Pa., Dec. 3, 2021 /PRNewswire/ -- Olympus announced today that Olympus Canada Inc. has been named one of Greater Toronto's Top Employers for the sixth consecutive year. The award recognizes a workplace culture that encourages a strong work-life balance along with increased employee engagement and recognition programs.

  • Updated

SPRING HOUSE, Pa., Dec. 3, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new TREMFYA® (guselkumab) efficacy and safety data from the Phase 3b COSMOS trial published in Annals of the Rheumatic Diseases (ARD), evaluating this selective interleukin (IL)-23 inhibitor in adults with active psoriatic arthritis (PsA) who demonstrated inadequate efficacy or intolerance to tumor necrosis factor inhibition (TNFi).1 Results showed significantly higher proportions of patients treated with TREMFYA had improvement in joint signs and symptoms and complete skin clearance versus placebo at week 24 in this documented TNFi-IRa patient population, which is often more difficult to treat.1 Furthermore, improvements in signs and symptoms of PsA were maintained or numerically increased through one year (week 48) among TREMFYA-randomized patients.1

  • Updated

RADNOR, Pa., Dec. 2, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Camber Energy, Inc. ("Camber") (NYSE: CEI). The action charges Camber with violations of the federal securities laws, including omissions and fraudulent misrepresentations about the company's business, operations and prospects. As a result of Camber's materially misleading statements, investors have suffered significant losses.

  • Updated

DOWNINGTOWN, Pa., Dec. 2, 2021 /PRNewswire/ -- SAVE (Suicide Awareness Voices of Education), West Pharmaceutical Services, and DCEF (Downingtown Community Education Foundation) to host a suicide prevention and awareness night in Downingtown, PA.

  • Updated

PHILADELPHIA, Dec. 2, 2021 /PRNewswire/ -- Luxury shoe designer Stuart Weitzman has made a transformative gift to the National Museum of American Jewish History (NMAJH), in recognition of which, the Museum has been renamed the Weitzman National Museum of American Jewish History, or "The Weitzman".

  • Updated

WEST CONSHOHOCKEN, Pa., Dec. 2, 2021 /PRNewswire/ -- Dicalite Management Group, LLC, ("Dicalite" or the "Company") is pleased to introduce the second and third products from Harvest Hero, a brand of value-added soil amendments and growing media targeting the cannabis industry and overall horticultural market.

  • Updated

MALVERN, Pa., Dec. 2, 2021 /PRNewswire/ -- Scala today announced the latest release of its flagship digital signage platform, Scala Enterprise version 12.60, which delivers unparalleled fidelity into network health for enterprises deploying Scala technology at scale. Scala, part of the STRATACACHE family of technology companies, has made significant resource investment to enhance the platform, having Enterprise 12.60 as the third major release in the past two years.